Latest Graft-versus-host disease Stories
A new discovery in mice may lead to new treatments that could make bone marrow transplants more likely to succeed and to be significantly less dangerous.
Columbia University Medical Center (CUMC) scientists have developed a way to recreate an individual's immune system in a mouse.
Researchers have identified a molecule that helps control the severity of graft-versus-host disease, a life-threatening complication for many leukemia patients who receive a bone-marrow transplant.
Organ transplant patients usually spend a lifetime on expensive and often dangerous anti-rejection drugs. But experts have announced that such drugs may not even be needed in the future.